MDMA Increases Glutamate Release and Reduces Parvalbumin-Positive GABAergic Cells in the Dorsal Hippocampus of the Rat: Role of Cyclooxygenase
- 696 Downloads
3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy) is a popular drug of abuse with well-documented acute effects on serotonergic, dopaminergic, and cholinergic transmitter systems, as well as evidence of long-term disruption of serotoninergic systems in the rat brain. Recently, it was demonstrated that MDMA evokes a delayed and sustained increase in glutamate release in the hippocampus. The purpose of the present study was to determine the role of inflammatory mediators in the MDMA-induced increase in glutamate release, as well as the contribution of inflammatory pathways in the persistent neurochemical toxicity associated with repeated MDMA treatment. Treatment with the non-selective cyclooxygenase (COX) inhibitor ketoprofen and the COX-2 selective inhibitor nimesulide attenuated the increase in extracellular glutamate in the hippocampus evoked by repeated MDMA exposure (10 mg/kg, i.p., every 2 h); no attenuation was observed in rats treated with the COX-1 selective inhibitor piroxicam. Reverse dialysis of a major product of COX activity, prostaglandin E2, also resulted in a significant increase in extracellular glutamate in the hippocampus . Repeated exposure to MDMA diminished the number of parvalbumin-positive GABA interneurons in the dentate gyrus of the hippocampus, an effect that was attenuated by ketoprofen treatment. However, COX inhibition with ketoprofen did not prevent the long-term depletion of 5-HT in the hippocampus evoked by MDMA treatment. These data are supportive of the view that cyclooxygenase activity contributes to the mechanism underlying both the increased release of glutamate and decreased number of GABA interneurons in the rat hippocampus produced by repeated MDMA exposure.
KeywordsMDMA Glutamate Cyclooxygenase GABA
This work was supported by awards from the National Institute on Drug Abuse DA 07427 (GG) and DA016886 (BY).
Conflict of Interest
The authors declare no conflicts of interest.
- Anneken JH, Gudelsky GA (2012) MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology 63(6):1022–1027Google Scholar
- Asi SS, Farhadi HM, Naghdi N, Choopani S, Samzadeh-Kermani A, Mehdizadeh M (2011) Non-acute effects of different doses of 3,4-methylenedioxymethamphetamine on spatial memory in the morris water maze in Sprague–Dawley male rats. Neural Regen Res 6:1715Google Scholar
- Asi SS, Farhadi HM, Mousavizadeh K, Samadikuchaksaraei A, Soleimani M, Jameie SB, Joghataei MT, Samzadeh-Kermani A, Hashemi-Nasl H, Mehdizadeh, M (2012) Evaluation of Bcl-2 Family Gene Expression in Hippocampus of 3,4-methylenedioxymethamphetamine Treated Rats. Cell J Vol 13, No 4, Winter 2012Google Scholar
- Capela JP, da Costa Araujo S, Costa VM, Ruscher K, Fernandes E, Bastos MD, Dirnagl U, Meisel A, Carvalho F (2012) The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons. Neurotoxicology. doi: 10.1016/j.neuro.2012.09.005
- Czeh B, Simon M, van der Hart MG, Schmelting B, Hesselink MB, Fuchs E (2005) Chronic stress decreases the number of parvalbumin-immunoreactive interneurons in the hippocampus: Prevention by treatment with a substance P receptor (NK1) antagonist. Neuropsychopharmacology 30:67–79PubMedCrossRefGoogle Scholar
- de Sola Llopis S, Miguelez-Pan M, Pena-Casanova J, Poudevida S, Farre M, Pacifici R, Bohm P, Abanades S, Verdejo Garcia A, Langohr K, Zuccaro P, de la Torre R (2008) Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. J Psychopharmacol 22:498–510PubMedCrossRefGoogle Scholar
- Kermanian F, Mehdizadeh M, Soleimani M, Ebrahimzadeh Bideskan AR, Asadi-Shekaari M, Kheradmand H, Haghir H (2012) The role of adenosine receptor agonist and antagonist on hippocampal MDMA detrimental effects; a structural and behavioral study. Metab Brain DisGoogle Scholar
- Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San DiegoGoogle Scholar
- Raj V, Liang HC, Woodward ND, Bauernfeind AL, Lee J, Dietrich MS, Park S, Cowan RL (2010) MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study. J Psychopharmacol 24:187–201PubMedCrossRefGoogle Scholar
- Riezzo I, Cerretani D, Fiore C, Bello S, Centini F, D'Errico S, Fiaschi AI, Giorgi G, Neri M, Pomara C, Turillazzi E, Fineschi V (2010) Enzymatic-nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (ecstasy) neurotoxicity. J Neurosci Res 88:905–916PubMedGoogle Scholar
- Wang X, Zhu SP, Kuang WH, Li J, Sun X, Huang MS, Sun XL (2009) Neuron apoptosis induced by 3,4-methylenedioxy methamphetamine and expression of apoptosis-related factors in rat brain. Sichuan Da Xue Xue Bao Yi Xue Ban 40(1000–2):1037Google Scholar